AI English summary of an SEC filing — figures as filed
Healthpeak Properties DOCHealthpeak said diluted net income for Q4 2023 was $0.13 per share (Q4 2022 $0.01), with Nareit FFO at $0.48 per share, FFO as Adjusted at $0.46 per share, and AFFO at $0.36 per share.
Key points
AI summaryHealthpeak said diluted net income for Q4 2023 was $0.13 per share (Q4 2022 $0.01), with Nareit FFO at $0.48 per share, FFO as Adjusted at $0.46 per share, and AFFO at $0.36 per share.
The company said diluted net income for the full year 2023 was $0.56 per share (2022 $0.92), with Nareit FFO at $1.79 per share, FFO as Adjusted at $1.78 per share, and AFFO at $1.53 per share, and that Total Same-Store Portfolio Cash (Adjusted) NOI growth was 4.8%.
Healthpeak said it expects its all-stock merger of equals with Physicians Realty Trust to close on March 1, 2024, subject to stockholder approvals and satisfaction of closing conditions. It also plans to enter into a new $750 million 5-year unsecured term loan.
Healthpeak said it sold a 65% interest in the Callan Ridge lab campus through a joint venture with Breakthrough Properties in January 2024. The joint venture valued Callan Ridge at $236 million, with net proceeds at closing of approximately $130 million. The company also gave 2024 full-year diluted Nareit FFO outlook of $1.54 to $1.60 per share, inclusive of the Physicians Realty Trust merger.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Diluted Net Income and FFO Metrics for Q4 2023
Healthpeak said diluted net income for Q4 2023 was $0.13 per share (Q4 2022 $0.01), with Nareit FFO at $0.48 per share, FFO as Adjusted at $0.46 per share, and AFFO at $0.36 per share.
Source · Based on the filing body and exhibits
Full-Year 2023 Diluted Results and Same-Store NOI Growth
The company said diluted net income for the full year 2023 was $0.56 per share (2022 $0.92), with Nareit FFO at $1.79 per share, FFO as Adjusted at $1.78 per share, and AFFO at $1.53 per share, and that Total Same-Store Portfolio Cash (Adjusted) NOI growth was 4.8%.
Source · Based on the filing body and exhibits
Physicians Realty Trust Merger and $750 million New Term Loan
Healthpeak said it expects its all-stock merger of equals with Physicians Realty Trust to close on March 1, 2024, subject to stockholder approvals and satisfaction of closing conditions. It also plans to enter into a new $750 million 5-year unsecured term loan.
Source · Based on the filing body and exhibits
Callan Ridge Joint Venture Stake Sale and 2024 Nareit FFO Outlook
Healthpeak said it sold a 65% interest in the Callan Ridge lab campus through a joint venture with Breakthrough Properties in January 2024. The joint venture valued Callan Ridge at $236 million, with net proceeds at closing of approximately $130 million. The company also gave 2024 full-year diluted Nareit FFO outlook of $1.54 to $1.60 per share, inclusive of the Physicians Realty Trust merger.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…